FDAFDA · Food and drugs·Recall number F-1523-2013
XYMOGEN EP Exclusive Patented Dietary Supplement Artriphen Clinically Tested to Support Healthy Joint Function, 90 and 180 capsule bottles
Published June 19, 2013 · Recall initiated: May 1, 2013
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Undeclared Soy and Milk on the label.
What to do
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Recall details
- Manufacturer
- Atlantic Pro Nutrients, Inc. dba XYMOGEN
- Distributor
- AK, AL, AR, AZ, CA, CO, CT, DE, FL, GA, IA, IL IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, NC, NJ, NM, NY, OH, OK, PA, RI, SC, TN, TX, UT, VA, WA, WI, WV, WY, District of Columbia and Hawaii
- Lot
- All SKUs
- Risk classification
- Class I
- Area (FDA)
- food
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.